Leucocyte depletion of perioperative blood transfusion does not affect long-term survival and recurrence in patients with gastrointestinal cancer
Authors:
- C J H Van De VeldeCVC J H Van De Velde
- cooperative clinical investigators of the Cancer Recurrence And Blood Transfusion (CRAB) study and the Transfusion Associated Complications = Transfusion Induced Complications? (TACTIC) studyCScooperative clinical investigators of the Cancer Recurrence And Blood Transfusion (CRAB) study and the Transfusion Associated Complications = Transfusion Induced Complications? (TACTIC) study
- 15 June 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 96 (7) , 734-740
Abstract
Background: Perioperative red blood cell (RBC) transfusion may be associated with a poor prognosis in cancer surgery. Allogeneic leucocytes are assumed to play a causal role. This study evaluated the long‐term effect of transfusion with leucocyte‐depleted (LD) blood in patients with gastrointestinal cancer. Methods: The Transfusion Associated Complications = Transfusion Induced Complications? (TACTIC) study is a multicentre randomized controlled trial evaluating the short‐term benefits of LD versus non‐LD RBC transfusions. The present study evaluated 5‐year survival and cancer recurrence among 512 patients with gastrointestinal cancer included in the TACTIC study. Results: Some 89·2 per cent of patients had a primary tumour and 79·7 per cent underwent surgery with curative intent; 243 patients received perioperative RBC transfusion (median 3 units). The 5‐year overall survival rate of patients with any type of gastrointestinal cancer was 50·8 per cent in the LD group and 45·8 per cent in the non‐LD group (P = 0·191). Corresponding 5‐year disease‐free survival rates were 60·0 and 56·6 per cent (P = 0·482), and recurrence rates 32·9 and 34·3 per cent (P = 0·864). Conclusion: Leucocyte depletion is not associated with better long‐term survival and lower recurrence rates in patients with gastrointestinal cancer. Copyright © 2009 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.Keywords
This publication has 18 references indexed in Scilit:
- Effects of blood transfusion with leucocyte depletion on length of hospital stay, respiratory assistance and survival after curative surgery for colorectal cancerActa Oncologica, 2007
- Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgeryBMJ, 2004
- Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction?Blood, 2001
- Effects of the combination of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancerBritish Journal of Surgery, 2000
- Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgeryThe Lancet, 1996
- Perioperative blood transfusion and cancer recurrence: meta‐analysis for explanationTransfusion, 1995
- Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancerThe Lancet, 1994
- Relationship between blood transfusion and tumour behaviourBritish Journal of Surgery, 1991
- Perioperative blood transfusion and colorectal cancer recurrence: A reviewJournal of Surgical Oncology, 1988
- RED BLOOD CELLS FOR CANCER PATIENTSThe Lancet, 1981